Home-Based Hematopoietic Cell Transplantation in the United States: Home HCT in the US.

[1]  A. Sung,et al.  House calls for stem cell transplant patients during the COVID-19 pandemic , 2020, Blood.

[2]  Satoshi Takahashi,et al.  Risk factors and survival impact of readmission after single-unit cord blood transplantation for adults , 2018, International Journal of Hematology.

[3]  M. Bar,et al.  Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Caroline S. Dorfman,et al.  The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation , 2018, Supportive Care in Cancer.

[5]  M. Remberger,et al.  Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation , 2018, International Journal of Hematology.

[6]  N. Dunavin,et al.  Using Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Tool to Explore Quality of Life in Patients Undergoing Autologous Stem Cell Transplantation in the Outpatient Setting , 2018 .

[7]  S. Parmar,et al.  Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma , 2017, European journal of haematology.

[8]  S. Tommasi,et al.  A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  M. Ardura,et al.  Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis , 2017, Bone Marrow Transplantation.

[10]  T. Braun,et al.  Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients , 2017, Mycopathologia.

[11]  P. Westervelt,et al.  Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation , 2016, Transplant infectious disease : an official journal of the Transplantation Society.

[12]  K. Myers,et al.  Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation. , 2016, Biology of Blood and Marrow Transplantation.

[13]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[14]  Caroline S. Dorfman,et al.  Cognitive Problems Following Hematopoietic Stem Cell Transplant: Relationships with Sleep, Depression, and Fatigue , 2016, Bone Marrow Transplantation.

[15]  K. Raj,et al.  Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies , 2016, Advances in hematology.

[16]  A. McBride,et al.  Outpatient Management of the Hematopoietic Stem Cell Transplant Patient , 2016, Journal of the advanced practitioner in oncology.

[17]  Stephanie J. Lee,et al.  Financial Impact of Allogeneic Hematopoietic Cell Transplantation on Patients and Families over 2-years: Results from a Multicenter Pilot Study , 2016, Bone Marrow Transplantation.

[18]  S. Crawford,et al.  Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  L. Traeger,et al.  Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation , 2015, Cancer.

[20]  M. B. Allen,et al.  Population aging and emergency departments: visits will not increase, lengths-of-stay and hospitalizations will. , 2013, Health affairs.

[21]  Junshik Hong,et al.  Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  M. Remberger,et al.  Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  Stephanie J. Lee,et al.  Pilot Study of Patient and Caregiver Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation , 2012, Bone Marrow Transplantation.

[24]  D. Sinderen,et al.  Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.

[25]  Jacqui Smith,et al.  Cohort differences in the availability of informal caregivers: are the Boomers at risk? , 2012, The Gerontologist.

[26]  M. Boeckh,et al.  How we treat cytomegalovirus in hematopoietic cell transplant recipients. , 2009, Blood.

[27]  W. Redd,et al.  Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature , 2009, Psycho-oncology.

[28]  N. Puig,et al.  Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation , 2006, Leukemia & lymphoma.

[29]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[30]  M. Remberger,et al.  Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation , 2005, Bone Marrow Transplantation.

[31]  M. Remberger,et al.  Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. , 2002, Blood.

[32]  O. Ringdén,et al.  Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial , 2000, Bone Marrow Transplantation.

[33]  W. Fleischhacker,et al.  EORTC QLQ‐C30 and FACT‐BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison , 2000, European journal of haematology.

[34]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[35]  R. Woodman,et al.  Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease , 1992, The Lancet.

[36]  Krish Patel,et al.  Febrile Neutropenia. , 2017, JAMA oncology.

[37]  A. Saven,et al.  Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.